Somatic mutations in the blood indicate a person's increased likelihood of developing a form of blood cancer within five years. In one study, people who have the mutation were 13 times more likely to develop myelodysplastic syndrome, leukemia or lymphoma compared with those who do not have mutated blood cells.
